OKUR
$4.02
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases.
Intraday
Recent News
Promising Penny Stocks To Watch In December 2025
As the Federal Reserve's meeting unfolds, investors are closely monitoring potential interest rate cuts that could influence market dynamics. Amid these developments, penny stocks continue to capture attention as a viable investment area, despite their seemingly outdated label. These smaller or newer companies can offer unique opportunities for growth and value, especially when they demonstrate strong financial resilience.
3 Promising Penny Stocks With Market Caps Under $200M
As the U.S. stock market shows signs of resilience with major indices like the Nasdaq and S&P 500 posting gains, investors are increasingly looking for opportunities beyond the usual tech giants. Penny stocks, a term that might seem outdated, still represent a compelling investment area by offering access to smaller or newer companies at lower price points. When these stocks are supported by strong financials and solid fundamentals, they can provide potential growth opportunities without many...
Companies Like OnKure Therapeutics (NASDAQ:OKUR) Could Be Quite Risky
NasdaqGM:OKUR 1 Year Share Price vs Fair Value Explore OnKure Therapeutics's Fair Values from the Community and select...